For citations:
Shatokhina E.A., Turkina A.G., Chelysheva E.Yu., Shukhov O.A., Petrova A.N., Kovrigina A.M., Kruglova L.S., Ranenko E.V., Nosikova P.G. Specificity of dermatological adverse events of BCR-ABL tyrosine kinase inhibitors and their effect on quality of life of patients with chronic myeloid leukemia. Medical alphabet. 2020;(6):72-76. (In Russ.) https://doi.org/10.33667/2078-5631-2020-6-72-76
Email this article 